Hirtle Callaghan & Co’s Navidea Biopharmaceuticals Inc. NAVB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2014
Q4
Sell
-1,500
Closed -$40K 624
2014
Q3
$40K Hold
1,500
0.01% 329
2014
Q2
$44K Hold
1,500
0.01% 372
2014
Q1
$56K Hold
1,500
0.01% 337
2013
Q4
$62K Hold
1,500
0.01% 309
2013
Q3
$80K Buy
+1,500
New +$80K 0.01% 300